From: MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
PTVEBRT
CTVCT
V90
1.00
V95
0.98
V100
0.18
0.32
V125
0.00
D100, Gy
69.60
72.00
D90, Gy
71.70
73.00
Dmin, Gy
67.42
71.06
Dmax, Gy
74.43
74.45
Dav, Gy
73.04
73.69